Evidence map›Paper›PMID 28035032›Full record

ArticleBioinformatics (Oxford, England)2017

Using genotype array data to compare multi- and single-sample variant calls and improve variant call sets from deep coverage whole-genome sequencing data.

Suyash S Shringarpure, Rasika A Mathias, Ryan D Hernandez, Timothy D O'Connor, Zachary A Szpiech, Raul Torres, Francisco M De La Vega, Carlos D Bustamante, Kathleen C Barnes, Margaret A Taub and 1 more

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Suyash S ShringarpureDepartments of Genetics and Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA.
Rasika A Mathias23 and Me Inc, Mountain View, CA, USA.
Ryan D HernandezDepartment of Epidemiology, Bloomberg School of Public Health, JHU, Baltimore, MD, USA.
Timothy D O'ConnorQuantitative Biosciences Institute, University of California, San Francisco, San Francisco, CA, USA.
Zachary A SzpiechDepartment of Epidemiology, Bloomberg School of Public Health, JHU, Baltimore, MD, USA.
Raul TorresDepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Francisco M De La VegaDepartments of Genetics and Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA.
Carlos D BustamanteDepartments of Genetics and Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA.
Kathleen C Barnes23 and Me Inc, Mountain View, CA, USA.
Margaret A TaubBiomedical Sciences Graduate Program, University of California, San Francisco, San Francisco, CA, USA.
CAAPA Consortium

Funding

New Approaches for Empowering Studies of Asthma in Populations of African DescentR01HL104608 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI BARNES, KATHLEEN C, KENNY, EIMEAR ELIZABETH · 2011 to 2022
$23.1M
NHLBI NIH HHS R01 HL104608
6 · The paper itself

Abstract

Motivation: Variant calling from next-generation sequencing (NGS) data is susceptible to false positive calls due to sequencing, mapping and other errors. To better distinguish true from false positive calls, we present a method that uses genotype array data from the sequenced samples, rather than public data such as HapMap or dbSNP, to train an accurate classifier using Random Forests. We demonstrate our method on a set of variant calls obtained from 642 African-ancestry genomes from the Consortium on Asthma among African-ancestry Populations in the Americas (CAAPA), sequenced to high depth (30X). Results: We have applied our classifier to compare call sets generated with different calling methods, including both single-sample and multi-sample callers. At a False Positive Rate of 5%, our method determines true positive rates of 97.5%, 95% and 99% on variant calls obtained using Illuminas single-sample caller CASAVA, Real Time Genomics multisample variant caller, and the GATK UnifiedGenotyper, respectively. Since NGS sequencing data may be accompanied by genotype data for the same samples, either collected concurrent to sequencing or from a previous study, our method can be trained on each dataset to provide a more accurate computational validation of site calls compared to generic methods. Moreover, our method allows for adjustment based on allele frequency (e.g. a different set of criteria to determine quality for rare versus common variants) and thereby provides insight into sequencing characteristics that indicate call quality for variants of different frequencies. Availability and Implementation: Code is available on Github at: https://github.com/suyashss/variant_validation. Contacts: suyashs@stanford.edu or mtaub@jhsph.edu. Supplementary information: Supplementary data are available at Bioinformatics online.

Indexed as

Polymorphism, Single NucleotideData AccuracyGenome, HumanGenomicsGenotypeGenotyping TechniquesHigh-Throughput Nucleotide SequencingHumansWhole Genome Sequencing

Identifiers

PMID28035032
PMCPMC5408850

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.